What is Guided Bone Regeneration?
GBR and GTR are dental surgical redress that use barrier membranes to direct the introduction of new bone and gingival tissue in areas the place there are inadequate portions or dimensions of bone or gingiva for perfect function, aesthetics, or prosthetic restoration. Reconstructive surgical treatment faces a hurdle with bone-regeneration techniques, whether or not the usage of autografts or allografts. Biomaterials serve as transient matrices for bone formation and tissue development, offering a unique surroundings and architecture. Certain cloth classes might also be extra or much less nicely matched to the ultimate building relying on the particular supposed software of the matrix, whether or not for structural support, drug transport capabilities, or both.
The market study is broken down by Type (Ceramic-based, Polymer-based, Growth factor-based, Cell-based and Others), by Application (Orthopedic Surgery, Bone Trauma, Dental Surgery and Others) and major geographies with country level break-up.
The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global Guided Bone Regeneration market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Geistlich Pharma (Switzerland), Keystone Dental (United States), Yantai Zhenghai Bio-tech (China), Bio-tech (India), Genoss (South Korea), MegaGen Impant (South Korea), Sunstar (Switzerland), OraPharma (United States), Biomedical Tissues (France) and Botiss (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Dentsply Sirona (United States), Zimmer Biomet (United States) and Lynch Biologics (United States).
Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Guided Bone Regeneration market by Type, Application and Region.
On the basis of geography, the market of Guided Bone Regeneration has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End Use, the sub-segment i.e. Hospital will boost the Guided Bone Regeneration market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Membrane, the sub-segment i.e. Reabsorbable Membranes will boost the Guided Bone Regeneration market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
In 2018, LYNCH Biologics LLC announced that it has entered into a transaction with Luitpold Pharmaceuticals Inc. (LPI), according to which LBIO acquires all rights to the "GEM 21S Growth Factor." Enhanced Matrix "and certain other assets related to LPI's dental regeneration business, which transfers all ownership rights to LBIO in order to commercialize" GEM 21S "globally, including the downstream formulation, filling and finishing rights. LYNCH Biologics will be the GEM 21SMarket its product for cranio-maxillofacial applications directly to dental surgeons, paradontologists and implant dentists along with a suite of complementary regenerative biological products. The terms of the transaction were not disclosed.
Market Trend
- Development of new treatment technology
Market Drivers
- Increase in prevalence of degenerative joint diseases
Opportunities
- Surging spending on healthcare facilities and treatment will boost the guided bone regeneration market
Restraints
- Expensive in treatment cost
Challenges
- Stringent regulatory guidelines on guided bone regeneration
Key Target Audience
Guided Bone Regeneration Companies, Guided Bone Regeneration Material Manufacturers, Guided Bone Regeneration Material Traders, Research and Development Institutes, Potential Investors, Regulatory Bodies, Hospitals and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand companys positioning regarding market value, volume and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.
Frequently Asked Questions (FAQ):
1. What all players are profiled in the study?
The standard version of the report profiles players such as Geistlich Pharma (Switzerland), Keystone Dental (United States), Yantai Zhenghai Bio-tech (China), Bio-tech (India), Genoss (South Korea), MegaGen Impant (South Korea), Sunstar (Switzerland), OraPharma (United States), Biomedical Tissues (France) and Botiss (Germany) etc.
2. Can we have customized study for Guided Bone Regeneration Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
3. What would be the Market Size of Guided Bone Regeneration Market by 2026?
Analysts at AMA estimates Guided Bone Regeneration Market to reach USD Million by 2026.